Vireo Growth (VREOF) Shares Outstanding (Weighted Average) (2020 - 2026)

Vireo Growth's (VREOF) quarterly Shares Outstanding (Weighted Average) came in at $1.1 billion in Q1 2026, up 6868.88% year-on-year from $15.5 million in Q1 2025, and up 35468.65% quarter-over-quarter from $3.0 million in Q4 2025.

Vireo Growth (VREOF) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends

Vireo Growth has disclosed Shares Outstanding (Weighted Average) across 7 years of filings, most recently posting $1.1 billion for Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $1.1 billion, up 6868.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 6868.88% YoY), and the FY2025 annual result was $3.0 million, down 98.32% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $1.1 billion for Q1 2026 at Vireo Growth, up from $3.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.1 billion in Q1 2026 to a low of $3.0 million in Q3 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $128.1 million (2022), against an average of $185.5 million.
  • Across the five-year window, Shares Outstanding (Weighted Average) jumped 943074.03% in 2022 and slumped 97.63% in 2023, its largest moves.
  • Vireo Growth's Shares Outstanding (Weighted Average) stood at $3.0 million in 2022, then soared by 439.89% to $16.4 million in 2023, then slumped by 81.48% to $3.0 million in 2024, then changed by 0.0% to $3.0 million in 2025, then jumped by 35468.65% to $1.1 billion in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $1.1 billion (Q1 2026), $3.0 million (Q4 2025), and $627.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.16 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 166.20 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 64.74 Mn
10 Vireo Growth - - 59.30 Mn 1.08 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.08 Bn
Dec 31, 2025 3.04 Mn
Sep 30, 2025 627.65 Mn
Jun 30, 2025 559.10 Mn
Mar 31, 2025 15.50 Mn
Dec 31, 2024 3.04 Mn
Sep 30, 2024 162.84 Mn
Jun 30, 2024 16.20 Mn
Mar 31, 2024 143.13 Mn
Dec 31, 2023 16.40 Mn
Sep 30, 2023 132.58 Mn
Jun 30, 2023 3.04 Mn
Mar 31, 2023 128.13 Mn
Dec 31, 2022 3.04 Mn
Sep 30, 2022 3.04 Mn
Jun 30, 2022 128.11 Mn
Mar 31, 2022 128.11 Mn
Dec 31, 2021 13,583.00
Sep 30, 2021 3.04 Mn
Jun 30, 2021 13,583.00